Results 11 to 20 of about 3,525 (160)
Cardiovascular Diabetology, 2018 Background Haptoglobin (Hp) functions as an antioxidant by binding with haemoglobin. We investigated whether serum Hp has a causal effect on macroangiopathy via Mendelian randomization (MR) analysis with common variants of the Hp gene in Chinese patients
Shiyun Wang +8 more
doaj +2 more sources
Characterization of lncRNA and mRNA profiles in rats with diabetic macroangiopathy.
PLoS ONE, 2020 Diabetic macroangiopathy is part of the most common serious complications of diabetes. Previous studies indicate that lncRNAs involved in the process of diabetes and another vascular disease.
Chan Yang +10 more
doaj +2 more sources
Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?
Cardiovascular Diabetology, 2017 Inflammatory response, oxidative stress, and endoplasmic reticulum (ER) stress are important pathophysiological bases of the occurrence and development of diabetes mellitus (DM) and macroangiopathy complications.
Shan-shan Yu, Jian-ling Du
doaj +2 more sources
Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio [PDF]
Biomolecules & Biomedicine, 2019 Chemerin is an adipocytokine that participates in glycolipid metabolism; however, its association with type 2 diabetes (T2DM) with lower extremity macroangiopathy (T2DM-V) has rarely been reported.
Mengxue Yang +10 more
doaj +2 more sources
Serum vitamin K1 associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes [PDF]
BMJ Open Diabetes Research & Care, 2020 ObjectiveVitamin K has proposed beneficial effects on cardiovascular health. We investigated whether serum vitamin K1 was associated with prevalence of microangiopathy and/or macroangiopathy.Research design and methodsSerum vitamin K was quantified in ...
Ida Bøgh Andersen +6 more
doaj +2 more sources
Diabetic macroangiopathy and self-monitoring of glucose
Медицинский совет, 2014 Diabetic macroangiopathy is a general term for atherosclerotic vascular diseases of large- and medium-caliber arteries in diabetes mellitus (DM). Macrovascular complications of diabetes leading to cardiovascular diseases (CVD) are the major cause of ...
OS Fedorova
doaj +2 more sources
Investigation of the Effects and Mechanisms of Mai Tong Formula on Lower Limb Macroangiopathy in a Spontaneous Diabetic Rat Model [PDF]
Journal of Diabetes Research, 2016 A new Chinese herbal formula called Mai Tong Formulae (MTF) has recently been used to treat lower limb macroangiopathy in type 2 diabetes mellitus (T2DM) patients.
Guangming Gong +3 more
doaj +2 more sources
World Journal of Traditional Chinese Medicine, 2018 Objective: Our aim was to investigate the correlation between free fatty acid (FFA) spectrum, blood stasis (BS) score, and macroangiopathy in type 2 diabetic patients with or without BS, as well as the possible relationship between BS and lipotoxicity ...
De-Liang Liu +8 more
doaj +2 more sources
The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats [PDF]
Journal of Diabetes Research, 2014 Purpose. The aim was to explore the effect of the chromium picolinate (CrPic) administration on the pancreas and macroangiopathy of type II diabetes mellitus rats. Methods.
Shan Huang +6 more
doaj +2 more sources
Cardiovascular Diabetology, 2018 Background The risk of diabetic complications is modified by genetic and epigenetic factors. p66Shc drives the hyperglycaemic cell damage and its deletion prevents experimental diabetic complications.
Gian Paolo Fadini +5 more
doaj +2 more sources